首页> 外文OA文献 >Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco

【2h】

Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco

机译：Valacyclovir抗病毒预防时代血清阳性肾移植受者细胞核病毒感染的特征及结果：摩洛哥的单中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Bouchra Rezzouk; Tarik Bouattar; Bouchra Belkadi; Rachid Razine; Rabia Bayahia; Naima Ouzeddoun; Loubna Benamar; Hakima Rhou; Najat Bouihat; Azeddine Ibrahimi; Myriam Seffar; Hakima Kabbaj;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco [J] . Bouchra Rezzouk, Tarik Bouattar, Bouchra Belkadi, Transplant Research and Risk Management . 2021,第a期

机译：杀虫预防时代血清阳性肾脏移植受者细胞核病毒感染的特征及成果：摩洛哥的单中心研究
2. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis. [J] . Boudreault AA, Xie H, Rakita RM, Transplant infectious disease: an official journal of the Transplantation Society . 2011,第3期

机译：接受抗病毒预防的供体血清阳性/受体血清阴性肾移植受者中迟发性巨细胞病毒病的危险因素。
3. Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis [J] . Limaye Ajit P., Green Margaret L., Edmison Bradley C., The Journal of Infectious Diseases . 2019,第5期

机译：高风险供体/受体 - 血清可口肝移植受者接受先发制疗法或抗病毒预防的前瞻性评估
4. Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisoeral transplantation: rejections and infections on 40 recipients during the early post-operative period. [C] . Zanfi C, Lauro A., Cescon M., International Small Bowel Transplant Symposium . 2009

机译：Daclizumab和Alemtuzumab作为成人肠道和多含量移植中的诱导剂：在术后期间的40名接受者中排斥和感染。
5. Post-transplant Kidney Function Prediction Using Pump Parameters, Anatomic Properties and Donor Recipient Characteristics [D] . Ghali, Hala 2019

机译：使用泵参数，解剖学性质和供体接受者特征预测移植后肾功能
6. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis [O] . A.A. Boudreault, H. Xie, R.M. Rakita, -1

机译：供体血清阳性/受体血清患者疾病的危险因素患者血清腺药物治疗抗病毒预防的肾脏移植受者
7. SP818IS THE VALACYCLOVIR PROPHYLAXIS EFFECTIVE FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS? [O] . Woo Yeong Park, Seong Sik Kang, Kyubok Jin, 2017

机译：SP818IS valacyclovir预防有效预防肾移植受者的细胞组虫病毒感染有效吗？
8. Randomized, Double-Blind Trial of Valacyclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection (ACTG 204) Documentation [R] . 1994

机译：晚期人类免疫缺陷病毒感染患者巨细胞病毒病毒的伐昔洛韦预防随机双盲试验（aCTG 204）文献

Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco

著录项

引文网络

相似文献

相关主题

期刊订阅